News

CVS/pharmacy brings back double Quarterly ExtraBucks promotion for limited time

BY Antoinette Alexander

WOONSOCKET, R.I. — CVS/pharmacy has announced the return of its Quarterly ExtraBucks Rewards, a promotion and additional savings opportunity for members of the ExtraCare loyalty program.

For a limited time only, members of the ExtraCare program, which has more than 70 million active cardholders, can sign up to double their Quarterly ExtraBucks Rewards earnings when they shop at the more than 7,500 locations nationwide from Sept. 16 through Dec. 15. To commemorate CVS/pharmacy’s 50th anniversary, shoppers can also take advantage of special deals and savings online and in-store through the month of September.

"ExtraCare members are always looking for more savings and rewards. To that end, Double Quarterly ExtraBucks Rewards is back by popular demand," stated Rob Price, SVP and chief marketing officer for CVS/pharmacy. "Simultaneously, we’re celebrating our 50th anniversary by offering tremendous savings to shoppers in September. It’s a great way to thank our loyal customers by providing them with even more value during each shopping trip."


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Target to open first stores in Quebec, Nova Scotia

BY Alaric DeArment

MISSISSAUGA, Ontario — With 68 stores already open across Canada, Target Corp. has released the timetable for the next batch of nearly two dozen, including the first stores in Quebec and Nova Scotia.

The mass merchandise retailer said it would open 14 stores on Sept. 17 and nine more on Oct. 18. A majority of the stores will feature a Starbucks, as well as a pharmacy. Most stores in Quebec will feature Brunet pharmacies, which will open in summer 2014.

Last month, Target announced a deal with McMahon Distributeur pharmaceutique Inc., a subsidiary of supermarket and drug store operator Metro, to operate pharmacies in Quebec under the Brunet banner. Under the deal, McMahon will enter agreements with pharmacist-owners who will own and operate the pharmacies, with McMahon providing supply chain and inventory services as well as operational support and the online MaSanté tool to let customers access their personal file online. The pharmacies will carry Target brands and provide customers with prescription, pharmacy and health consultation services.

"We look forward to opening our first stores in Quebec and Nova Scotia as we carry out an unprecedented retail expansion covering all 10 provinces across Canada this year," Target Canada president Tony Fisher said. "Quebec, Nova Scotia and Ontario offer a variety of culturally diverse markets, and we look forward to serving our new guests and engaging with these great communities."


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

NCPA reiterates stance on compounding to House Energy and Commerce Committee

BY Michael Johnsen

ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday reiterated its stance on compounding to the House Energy and Commerce Committee of the U.S. House of Representatives. 

The House committee has conducted an investigation and held several hearings into how the meningitis outbreak was handled by the Food and Drug Administration and state regulators and, as Congress returns from its August recess, the panel is actively considering what policy or legislative changes may be necessary to avoid a similar public health crisis from happening again, NCPA reported. 

“Compounding is the backbone of pharmacy practice and for many decades independent community pharmacists have provided millions of adults, children and animals with access to safe, effective and affordable medications through compounding services,” Hoey wrote to committee chairman Reps. Fred Upton, R-Mich., and ranking member Henry Waxman, D-Calif. “Compounding can help bridge the gaps during times of drug shortages. Drug shortages have nearly tripled, according to the FDA, and their impact can be devastating.”

NCPA expressed its dissent of a Senate proposal (S. 959) as currently written because it would inadvertently “create unnecessary federal regulatory burdens, hamper independent community pharmacies from providing medications to patients with unique health needs, and far exceeds a targeted approach to prevent another tragedy such as NECC.” Specifically, S. 959 would require community pharmacies to report directly to the FDA when they are compounding medications to alleviate a drug shortage. In addition, S. 959 would jeopardize patient access to vital medications by directing the FDA to maintain a “do not compound” list which could potentially be used by the agency to prevent compounding in response to a doctor’s prescription for medications such as hormone medications, thyroid preparations, promethazine gels and medications to treat autism, NCPA suggested. 

Instead, NCPA supports the efforts of Rep. Morgan Griffith, R-Va., to develop bipartisan House legislation based on the “discussion draft” legislation posted on the committee’s website. The proposal “rightfully maintains state board of pharmacy oversight of traditional compounding pharmacies while strengthening badly needed two-way communications between the FDA and state boards of pharmacy.” Poor coordination and communication between FDA and state boards of pharmacy were a vital factor that prevented regulators from stopping or mitigating the impact of the meningitis outbreak, NCPA noted. Other provisions in the legislation would protect patient access to essential medications from pharmacies at hospitals and physician’s offices, yet clarify the authority of FDA and other regulators to go after any bad actors, such as the New England Compounding Center.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?